KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer
Sign Up to like & getrecommendations! Published in 2024 at "Molecular Carcinogenesis"
DOI: 10.1002/mc.23792
Abstract: Ovarian cancer (OCa) is the deadliest of all gynecological cancers. The standard treatment for OCa is platinum‐based chemotherapy, such as carboplatin or cisplatin in combination with paclitaxel. Most patients are initially responsive to these treatments;… read more here.
Keywords: treatment; kdm1a lsd1; oca; inhibition ... See more keywords
Capsaicin: A "hot" KDM1A/LSD1 inhibitor from peppers.
Sign Up to like & getrecommendations! Published in 2020 at "Bioorganic chemistry"
DOI: 10.1016/j.bioorg.2020.104161
Abstract: Capsaicinoids are plant secondary metabolites, and capsaicin is the main principal that responsible to the pungency of chili peppers, with widely application as food additive. In our study, capsaicin was characterized as lysine specific demethylase… read more here.
Keywords: capsaicin hot; inhibitor; lsd1 inhibitor; kdm1a ... See more keywords
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double strand break repair and augments efficacy of temozolomide in glioblastoma.
Sign Up to like & getrecommendations! Published in 2023 at "Neuro-oncology"
DOI: 10.1093/neuonc/noad018
Abstract: BACKGROUND Efficient DNA repair in response to standard chemo and radiation therapies often contribute to GBM therapy resistance. Understanding the mechanisms of therapy resistance and identifying the drugs that enhance the therapeutic efficacy of standard… read more here.
Keywords: dna; inhibition; kdm1a lsd1; tmz ... See more keywords